West Pharmaceutical
280 hedge funds and large institutions have $4.93B invested in West Pharmaceutical in 2016 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 105 increasing their positions, 115 reducing their positions, and 32 closing their positions.
191% more call options, than puts
Call options by funds: $1.17M | Put options by funds: $402K
0.86% less ownership
Funds ownership: 91.34% → 90.47% (-0.86%)
3% less capital invested
Capital invested by funds: $5.07B → $4.93B (-$134M)
9% less repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 115
3% less funds holding
Funds holding: 289 → 280 (-9)
16% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 32
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$57.4M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$32.6M |
| 3 |
Select Equity Group
New York
|
+$31.9M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$20.7M |
| 5 |
Goldman Sachs
New York
|
+$19.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$45.5M |
| 2 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$41.1M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$35.7M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$19.6M |
| 5 |
DIA
Denver Investment Advisors
Denver,
Colorado
|
-$17.8M |
WST Hedge Fund Activity: Q3 2016 in Review
280 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2016, worth a combined $4.93B — down 2.6% from $5.07B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of WST and 27 opened new positions — a net loss of 5 holders — while 115 trimmed existing stakes and 105 added.
The largest buyer was AllianceBernstein, adding an estimated $57.4M. The largest seller was Royal Bank of Canada, cutting an estimated $45.5M.
- 280 institutional investors held West Pharmaceutical (WST) as of Q3 2016, down from 289 in Q2 2016.
- Funds reported $4.93B of West Pharmaceutical stock for Q3 2016, down 2.6% quarter-over-quarter.
- 27 funds opened new West Pharmaceutical positions in Q3 2016 and 32 closed out, a net change of -5 holders.
- The largest West Pharmaceutical buyer in Q3 2016 was AllianceBernstein, an estimated $57.4M added.
- The largest West Pharmaceutical seller in Q3 2016 was Royal Bank of Canada, an estimated $45.5M sold.
Based on aggregated 13F filings for Q3 2016.